Interferon Beta-1a Treatment Promotes SARS-CoV-2 Mrna Vaccine Response in Multiple Sclerosis Subjects
MULTIPLE SCLEROSIS AND RELATED DISORDERS(2022)
Key words
BNT162b2-mRNA coronavirus-19 vaccine,Disease modifying therapies,Multiple sclerosis,Humoral response,SARS-CoV-2 spike protein
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined